Morgan Stanley raised the firm’s price target on American Healthcare REIT (AHR) to $45 from $37 and keeps an Overweight rating on the shares. Senior housing occupancy and pricing is “off to one of the best years on record,” but senior housing may still have more upside given supply and demand fundamentals, the analyst tells investors in a note analyzing fundamentals across senior housing, life science and outpatient medical REITs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT: Strong Financial Performance and Strategic Acquisitions Drive Buy Rating
- American Healthcare REIT price target raised to $40 from $35 at Citizens JMP
- American Healthcare REIT Reports Q1 2025 Results, Raises Guidance
- American Healthcare REIT Reports Q1 2025 Financial Results
- American Healthcare REIT reports Q1 normalized FFO 38c , consensus 37c